Events > Exporting Health Tech & Life Sciences to Japan
row-start col-md-7 #top-section top-section new-section

Exporting Health Tech & Life Sciences to Japan

Tuesday, 16 March 2021 9:00 am to 10:30 am


Join key officials from the Department for International Trade (DIT) South West, DIT Japan, DAC Beachcroft and Matador Japan for a comprehensive look at the Japanese digital healthcare and medical devices market in 2021.


Register Your Place Now - Click Here


What will I learn?

This webinar is suitable for both new and existing exporters to Japan and will cover steps to start or further expand presence in the Japanese market. Both the legal and regulatory environments will also be discussed, ensuring attendees receive the most relevant updates on market conditions.


Please scroll down the page to see the list of speakers.


Who is this event for?

This webinar is open to healthcare and life science businesses who are experienced exporters.

Unfortunately we are unable to accept bookings bookings from service providers/intermediaries.


Register Your Place Now - Click Here


Why Japan?

Japan is currently the third largest economy in the world and in 2019, UK exports to Japan had increased 8.5% from the previous year. Japan is an advanced economy and a stable place for the UK to do business, with strong economic and political ties between the two countries cemented with the signing of a free trade agreement (CEPA) in September 2020. As both the world’s second largest healthcare and medical devices market, timing is optimal for UK healthcare and life science companies to consider exporting to Japan.

All Japanese citizens are covered by public medical insurance systems and with generally high levels of health consciousness, the demand for innovative healthcare solutions has never been higher. Japan is an aging society which has created challenges for the pre-existing healthcare system; consequently, the government continues to focus on a strategy centred around digital healthcare to relieve existing challenges.

These new technological developments are creating a more stable and accessible healthcare model; solutions in demand, but not limited to, include telehealth, wearable devices, mobile health, telemedicine, personalised medicine and information technology solutions.

In the South West, companies may not realise that they indeed either have an opportunity to export, or, expand their exports significantly in the Japanese market. Opportunities in the market exist particularly within digital health, but also within diagnostics, regenerative medicine, novel medical treatments, licensing and R&D collaboration. But it’s not the easiest market to navigate and it can take time and commitment. Join this event to explore your potential in the market and begin your export journey to Japan, with help and advice from our experts.

Please find enclosed HERE the Japan Life Sciences market overview for 2021 for your information.


Register Your Place Now - Click Here


Please Note: We will send you details of the online platform and login details prior to the event.


This event is organised in association with the Western Gateway Partnership.


Business West (delivery partner for the Department for International Trade)  is committed to providing a professional, friendly, safe and welcoming environment for all participants at its events. Inappropriate behaviour on video, audio & chat facilities will not be tolerated during any portion of a meeting or event. It will be at the sole discretion of the host/facilitator to immediately expel any participants from the event if their behaviour is deemed to be inappropriate and/or offensive.

Privacy Policy

We take your data very seriously and are committed to the privacy and security of it. This event is organised by Business West, delivery partner for The Department of International Trade for the SW,  their privacy policies are available at DIT Personal Information Charter.

row-end col-sm-12 col-md-5
row-start col-xs-12 colour-section row-end


Jamie Shaw - Healthcare Life Science Sector Specialist at DIT South West - Western Gateway

Jamie comes with significant private sector experience where most recently he was based overseas as an International Account Manager for China’s largest medical device manufacturer, Mindray. Jamie worked with overseas subsidiaries within the business and supported/implemented new direct/indirect sales channels in a number of territories; working with both public and private sector healthcare institutions.


Sarah Hildersley - Market Specialist, Department for International Trade South West

With extensive business development experience as a British diplomat all over the world helping UK companies achieve sales success, and private sector experience from Iraq, Sarah now advises South West companies on their approach to selling in complex markets in Asia, Latin America and the Middle East.  Having worked extensively with small businesses and some of the largest UK firms, Sarah is well placed to help our companies secure sales in the most efficient way.  Sarah helps companies analyse their route to market and to secure sustainable sales.  She recently took on the expanded role of High Growth Markets Specialist in recognition of our levelling-up plans to help South West companies break into new markets


Akiko Okamoto - Senior Trade Adviser, Digital Health / Life Sciences, DIT Japan


Andrew Clare - Legal Director, DAC Beachcroft

Andrew Clare is a corporate lawyer in the firm's Manchester office.

Andrew has been involved in a number of ground breaking transactions at previous law firms, including:

  • US$1.2 billion refinancing of a major Japanese telecoms company, then the largest financing deal of its type ever done in Asia;
  • Simultaneous disposal of shares and assets in a brand name telecoms group across three European jurisdictions;
  • Reverse takeover and IPO of a significant Scandinavian cosmetics company;
  • Global business process outsourcing (BPO) agreement for a major pharmaceutical group.

Having spent almost a decade in Japan, Andrew also has particular expertise in advising Japanese businesses both in Japan and the UK and is able to work in the Japanese language.


John Bolger - Founder, Matador Japan

Matador has a track record in building bridgeheads in Japan for overseas technology companies, specialising in selling software and information products to the pharmaceutical industry. Our experience spans drug discovery, clinical development, regulatory, manufacturing, quality, medical, safety and promotional technologies. We provide everything needed to establish sales pipeline and win first customers without the need to make a significant financial investment and without the accompanied risk.

Our experienced, multi-cultural team specialises in researching, cold-calling, qualifying, selling to and closing well-constructed pipeline for our overseas partners. Our product specialists can deep dive with clients, support POCs or implementations and operate as your local first-line helpdesk to ensure your clients are successful at deriving value from their investment. Matador pride ourselves on the high-quality relationships we build with both clients and partners.